International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released Nov 14, 2018, after the close
10-Q filed Nov 14, 2018, 45 days after period end · 0001564590-18-029577
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Revenue | $3.20M | $1.85M | $1.94M | $2.14M |
| Net Income | $121.00K | -$2.16M | $414.00K | -$539.00K |
| EPS Diluted | $0.02 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| -$0.54 |
| -$0.30 |
| -$0.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
